Related Experiment Video
Updated: Mar 29, 2026

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Addressing viral resistance through vaccines.
Catherine Laughlin1, Amanda Schleif1, Carole A Heilman1
1Division of Microbiology & Infectious Diseases, National Institute of Allergy & Infectious Diseases (NIAID), NIH, 5601 Fishers Lane, Bethesda, MD 20852, USA.
Antiviral resistance is a growing global health threat. Next-generation vaccines could combat this, but require new strategies focusing on high-risk populations rather than general public health.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Antimicrobial resistance is a significant global health concern.
- Antiviral resistance, though less emphasized than antibiotic resistance, is an emerging threat.
- Current vaccination strategies need to evolve to address viral resistance.
Purpose of the Study:
- To explore the challenges and propose new models for developing next-generation viral vaccines.
- To address the growing issue of antiviral resistance through innovative vaccination approaches.
- To shift the focus of vaccination strategies towards high-risk populations.
Main Methods:
- Literature review on current vaccination strategies and antiviral resistance.
- Analysis of hurdles in next-generation vaccine design, evaluation, and implementation.
- Proposal of a targeted vaccination model for high-risk groups.
Main Results:
- Next-generation viral vaccines face challenges in design, evaluation, and implementation.
- A shift from broad public health focus to targeted, high-risk population strategies is suggested.
- This targeted approach aims to curb antiviral resistance more effectively.
Conclusions:
- Developing next-generation viral vaccines is crucial for combating antiviral resistance.
- A new vaccination model prioritizing high-risk individuals may be more effective.
- This strategy requires careful consideration of vaccine development and deployment hurdles.
More Related Videos
Related Concept Videos
Vaccinations
Vaccines
Viral Mutations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

